دورية أكاديمية

Incidence and Timing of Graft Versus Host Disease (GVHD) After Daratumumab(Dara) Anti CD38 Therapy Post Allogeneic Transplant (alloHCT)for Myeloma

التفاصيل البيبلوغرافية
العنوان: Incidence and Timing of Graft Versus Host Disease (GVHD) After Daratumumab(Dara) Anti CD38 Therapy Post Allogeneic Transplant (alloHCT)for Myeloma
المؤلفون: Krishnan, Amrita, Parameswaran, Hari, Chhabra, Saurabh, Biran, Noa, Stiller, Tracy, Htut, Myo, Karanes, Chatchada, Nathwani, Nitya, Rosenzweig, Michael, Somlo, George, Sahebi, Firoozeh, Duarte, Lupe, Richter, Joshua
المصدر: In Clinical Lymphoma Myeloma and Leukemia February 2017 17(1) Supplement:e71-e71
قاعدة البيانات: ScienceDirect
الوصف
تدمد:21522650
DOI:10.1016/j.clml.2017.03.129